Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avita Medical Inc (NQ: RCEL )

8.160 +0.240 (+3.03%)
Streaming Delayed Price Updated: 1:45 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avita Medical Inc

< Previous 1 2 Next >
AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer
From AVITA Medical
Via GlobeNewswire
AVITA Medical Inc. (NASDAQ: RCEL) Records 52-Week High Thursday Morning
Via Investor Brand Network
AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
From AVITA Medical
Via GlobeNewswire
AVITA Medical Inc. (NASDAQ: RCEL) is a Stock Spotlight on 5/11
Via Investor Brand Network
AVITA Medical to Announce First Quarter 2023 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Update to Automation Device
From AVITA Medical
Via GlobeNewswire
AVITA Medical Appoints New Non-Executive Member to the Board of Directors
From AVITA Medical
Via GlobeNewswire
AVITA Medical Appoints New Non-Executive Member to the Board of Directors
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the TD Cowen 43rd Annual Health Care Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide 2023 Financial Guidance
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference Call
From AVITA Medical
Via GlobeNewswire
AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders
From AVITA Medical
Via GlobeNewswire
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair
From AVITA Medical
Via GlobeNewswire
AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical® to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Third Quarter 2022 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Third Quarter 2022 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer
From AVITA Medical
Via GlobeNewswire
Investor Webinar Briefing (RCEL, AVH)
Valencia, California and Melbourne, Australia--(Newsfile Corp. - September 19, 2022) - AVITA Medical, Inc. (NASDAQ: RCEL) (ASX: AVH), a regenerative... 
Via Newsfile
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.